Cardiology
The heart pumps blood to the vessels, ensuring that all our cells are properly nourished. Disorders of this organ are dangerous diseases that must be diagnosed and treated quickly.
Diseases and defects of the cardiovascular system are one of the most common complaints that patients report to the doctor. All diseases that affect the heart require a quick diagnosis and immediate treatment, which allows for a significant improvement in the quality of life, as well as stopping the development of severe and very dangerous processes.
Małgorzata Kwissa, MD, PhD
Cardiology specialist. A graduate of the Faculty of Medicine at the Medical University of Karol Marcinkowski in Poznań. Scientifically associated with the Department of Intensive Cardiac Therapy and Internal Diseases of the Dr. H. Święcicki in Poznań, during his doctoral studies. He is a member of the Polish Cardiac Society. She broadens her knowledge in the field of cardiology and professional competences by participating in numerous courses and scientific conferences.
Her interests include in particular sports cardiology and non-invasive diagnostics of heart diseases in adults.
In our offer you will find both a specialist cardiological consultation and a diagnostic test of the heart, ECG and echocardiography.
The most common complaints that cardiological patients report to us:
- getting tired too quickly
- dizziness
- fainting, chest pain
- palpitations, arrhythmia
- swelling of the lower limbs
- feeling short of breath
Price list
Małgorzata Kwissa, MD, PhD
Cardiac consultation
PLN 250(ECG test is included in the price of the consultation)Cardiology consultation + ECG + Echocardiogram
PLN 300
Contact
Address
- st. Barwicka 14A, 60-192 Poznań
Contact number
Email for booking
Work hours
- Mon. - Fri: 10 - 20, Sat: 10 - 14
Heart Diseases in Contemporary Europe: A Cardiological Perspective
Heart disease remains one of the main health challenges in contemporary Europe, constituting a significant cause of death and reduced quality of life. In recent decades, thanks to advances in the field of cardiology, the understanding of the mechanisms underlying these diseases has advanced significantly, but they remain a serious threat to public health. This article aims to present the current state of knowledge on the epidemiology, treatment and challenges of heart disease in Europe, with an emphasis on modern cardiology approaches.
Epidemiology of Heart Diseases in Europe
The epidemiology of heart disease in Europe presents a complex picture that varies depending on region, lifestyle and availability of health care. A study conducted by the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) consortium provides valuable information on the relationship between circulating metabolites and the risk of coronary heart disease in a large European cohort [1]. This study analyzed 141 metabolites, 24 of which showed a significant association with incident coronary heart disease, including phosphatidylcholines, lysophosphatidylcholines, amino acids, and sphingolipids. These findings highlight the importance of metabolic testing in assessing heart disease risk.
Another study, DYSIS II Europe, focused on achieving LDL-cholesterol targets among patients with acute and chronic coronary artery disease [2]. The results of this study indicate significant differences in achieving therapeutic goals between patients with acute and chronic coronary artery disease, which is crucial for treatment and prevention strategies.
Modern Cardiology in the Treatment of Heart Diseases
Cardiology, as a medical discipline, is constantly evolving, offering new methods of diagnosing and treating heart diseases. Technological advances, including the development of advanced imaging techniques and minimally invasive procedures, have significantly improved outcomes for heart disease patients in Europe.
One of the key challenges in treating heart disease is managing overweight and obesity, which are important risk factors. The Euroaspire IV study, conducted by the European Society of Cardiology, reveals how these risk factors are managed in 27 European countries [3]. The study results indicate significant differences in approaches to the treatment of overweight and obesity among patients with coronary artery disease, which emphasizes the need to individualize therapy and increase awareness of a healthy lifestyle.
Challenges and Solutions in European Cardiology
The challenges facing modern cardiology in Europe are diverse and include not only treatment, but also education and prevention. A comparison of training in structural heart disease in the USA, Canada and Europe sheds light on differences in cardiological approaches and may indicate directions of development for European cardiology [4]. Understanding these differences is key to developing more effective treatment and education strategies.
Analysis of specific patient cases and interviews with cardiologists and specialists can provide valuable insights into the realities of heart disease management in Europe. Case studies allow you to understand individual aspects of treatment, as well as the challenges faced by patients and doctors. Interviews with experts, in turn, can reveal the latest trends in cardiology research, as well as practical aspects of using new treatment methods in everyday practice.
The future of Cardiology and Heart Diseases in Europe
In the context of the future of cardiology in Europe, it is important to pay attention to developing technologies such as artificial intelligence and telemedicine, which may revolutionize the diagnosis and treatment of heart diseases. Moreover, the growing interest in personalized medicine and genetics in cardiology opens new possibilities for more effective and tailored therapies.
Summation
In conclusion, heart disease in Europe remains a serious health challenge, but progress in the field of cardiology offers hope for better treatment and prevention outcomes. Modern cardiology, with its modern diagnostic and therapeutic methods, plays a key role in the fight against these diseases. However, there is still a need for further research, innovation and education to better prevent heart disease in Europe.
REFERENCES
[1] Cavus, E., Karakas, M., Ojeda, F., et al. (2019). Association of Circulating Metabolites With Risk of Coronary Heart Disease in a European Population: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium. JAMA Cardiology.
[2] Ferrières, J., de Ferrari, G.D., Hermans, M., et al. (2018). Predictors of LDL-cholesterol target value achievement differ in acute and chronic coronary heart disease patients: Results from DYSIS II Europe. European Journal of Preventive Cardiology.
[3] Kotseva, K., Backer, G., Bacquer, D., et al. (2018). Management of Overweight and Obesity In Patients With Coronary Heart Disease Across 27 Countries In Europe: Results From Euroaspire IV Survey of the European Society of Cardiology. GlobalHeart.
[4] Marmagkiolis, K., Toutouzas, K., Kavinsky, C., Cilingiroglu, M. (2018). Structural heart disease training in the USA, Canada, and Europe. Catheterization and Cardiovascular Interventions.